The dialysis provider's strong financial position could lead to acquisitions and further growth.
The company is seen as the next likely candidate in the biotech sector's takeover hit parade.
Leadership changes at one of the world's largest and most underappreciated biotechs bode well for investors.
J&J and Pfizer are among the sector's duds.
Blue chips in this sector can be poison pills for your portfolio right now, so a dose of caution is needed.
The drugmaker is no Wall Street darling. But that hasn't stopped hedge funds from taking interest.
| Tags: | AmgenKim PetersonPfizer |
VIDEO ON MSN MONEY
DATA PROVIDERS
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
TOP STOCKS
When it comes to efficiency gains, a watt saved is a watt earned.
MARKET DISPATCHES
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
FRUGAL COOL
Starting Monday, this site is joining forces with MSN Money Smart Spending. Here's why.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
SMART SPENDING
Think saving money, paying bills, comparing prices and shopping for deals take way too much work? All of these can be done with very little effort on your part.
SMART TAXES
The IRS is struggling to combat identify thieves who file fraudulent tax returns in the names of older residents who don't need to file.
